Formation of the Bonus Deferral Working Group

For the 2020 proxy season, members of the Investors for Opioid and Pharmaceutical Accountability (IOPA) and more than dozen pharmaceutical manufacturers and distributors as well as retail pharmacies have agreed to participate in a facilitated Working Group on the topic of bonus deferrals as an alternative to the 14a-8 process.  Investors have withdrawn or agreed not to file resolutions on bonus deferrals at companies that have committed to work on the issue and whose annual meetings occur during the time the Working Group is convened.     

To learn more about this initiative, please contact Donna Meyer of Mercy Investment Services,


Sign Up for our eNewsletter

* indicates required